NCT00765128View on ClinicalTrials.gov

Intravenous Ketorolac for Postoperative Pain in Percutaneous Nephrolithotomy

PHASE4CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Renal CalculusKidney Stones
Interventions
DRUG

Ketorolac

90 mg ketorolac in 1 L of normal saline infused at 40-120 mL/hr for 18.5-23 hours beginning 0.5 hours after the end of surgery.

DRUG

Placebo

1 L of normal saline infused at 40-120 mL/hr for 18.5-23 hours beginning 0.5 hours after the end of surgery.

Trial Locations (1)

85054

Mayo Clinic, Phoenix

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER